secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001493152-24-015192
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx regains Nasdaq compliance after $17.2M fundraising; hearing cancelled
------------------------------------------------------------------------------

- Nasdaq confirmed RenovoRx met $2.5M minimum stockholders' equity requirement; prior deficiency remedied.
- Company raised $17.2M in gross proceeds in 2024, extending cash runway into 2026.
- Hearing before Nasdaq Hearings Panel cancelled; no ongoing monitor required.
- Management to focus on Phase III TIGeR-PaC trial progress, TAMP pipeline expansion, and business development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315224015192/0001493152-24-015192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315224015192/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer